BBOT to Participate in the Jefferies Global Healthcare Conference in London

BridgeBio Oncology Therapeutics (Nasdaq: BBOT) announced that its leadership team will present at the Jefferies Global Healthcare Conference on Monday, November 17, 2025 at 2:30 p.m. GMT.

Rhea-AI Summary

BridgeBio Oncology Therapeutics (Nasdaq: BBOT) announced that its leadership team will present at the Jefferies Global Healthcare Conference on Monday, November 17, 2025 at 2:30 p.m. GMT. A live webcast will be available on the company’s Events page at https://investors.bbotx.com/news-events/events. A replay of the webcast will be accessible for at least 90 days after the event.

Argus Nov 4 session

-1.55% close to close Open Argus

Details

News Market Reaction – BBOT

On Nov 4, the first trading day after this news, BBOT closed 1.55% below the previous close.

Data tracked by StockTitan Argus for the Nov 4 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SOUTH SAN FRANCISCO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced that members of its leadership team will participate in a presentation at the Jefferies Global Healthcare Conference on Monday, November 17, at 2:30 p.m. GMT.  

A live webcast of the presentation will be accessible on the “Events” page of the BBOT website at https://investors.bbotx.com/news-events/events. A replay of the webcast will be available for at least 90 days following the event.

About BBOT
BBOT is a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Kα malignancies. BBOT has the goal of improving outcomes for patients with cancers driven by the two most prevalent oncogenes in human tumors. For more information, please visit www.bbotx.com and follow us on LinkedIn.

BBOT Contacts:

Investor Contact:
Heather Armstrong, Head of Investor Relations
BBOT
Investors@BBOTx.com

Media Contact:
Jake Robison
Inizio Evoke Comms
Jake.robison@inizioevoke.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will BBOT present at the Jefferies Global Healthcare Conference in 2025?

BBOT will present on Monday, November 17, 2025 at 2:30 p.m. GMT.

How can investors watch the BBOT presentation at Jefferies on November 17, 2025?

Watch the live webcast on BBOT’s Events page at https://investors.bbotx.com/news-events/events.

Will there be a replay of the BBOT Jefferies presentation and for how long?

Yes. A replay will be available for at least 90 days following the event.

What topics will BBOT likely cover during the Jefferies Global Healthcare Conference presentation?

Company leadership typically covers corporate updates, clinical program progress, and strategy; expect an overview and program updates.

Is the BBOT presentation at Jefferies on November 17, 2025 open to the public?

Yes. The presentation is accessible via a public live webcast on the company’s Events page.

Where can I find the BBOT webcast if the live event is missed on November 17, 2025?

Access the replay on the same Events page at https://investors.bbotx.com/news-events/events within the 90-day replay window.